Whether it's a class project, social campaign, or personal expression, North Penn students use tools such as AI video generation tools, Free AI Face Swap, and GTA Style Art Generator to create ...

Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...

Details of the Poster Presentations Poster Number: 750-P Abstract Title: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study ...

Details on the presentation can be found below. A copy of the Company's poster presentation will be available under the Scientific Presentations tab of the Tonix website at following the conference.

Presentation Time: Saturday, May 31, 2025, at 1:30PM to 4:30PM CDT Location: McCormick Place Convention Center Session / Track: Lung Cancer – Non-Small Cell Metastatic Abstract Number: 8560 ...

HONG KONG, May 6, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX:1672, "Ascletis") announces oral and poster presentations on preliminary studies of ASC47, an adipose-targeted, muscle-preserving ...

Spyre Therapeutics Announces Poster Presentations at Digestive Disease Week (DDW) 2025 Including Up to Eight months of Follow-up from an Ongoing Phase 1 Trial of SPY001 By Spyre Therapeutics, Inc.

Thousand Oaks, Calif.-based Capsida Biotherapeutics (Capsida) has announced its slate of seven scientific presentations, three oral and four in poster form, that have been accepted for the 28th Annual ...

Sutro Biopharma announced poster presentations at the prestigious 2025 American Association for Cancer Research (AACR) Annual Meeting, highlighting the company's engagement with the oncology ...

Business Wire Radiant Biotherapeutics Announces Poster Presentation at 2025 American Association for Cancer Research (AACR) Annual Meeting By Business Wire Updated April 25, 2025 4:47 PM ...

TORONTO & PHILADELPHIA — Radiant Biotherapeutics, a preclinical biotechnology company developing an antibody platform to deliver first-in-class transformative therapies for patients facing ...